Eli Lilly’s Mounjaro added to China’s state insurance list for diabetes treatment
Original source: https://www.investing.com/news/stock-market-news/eli-lillys-mounjaro-added-to-chinas-state-insurance-list-for-diabetes-treatment-4394853
Read More »Eli Lilly drops CVS as employee drug plan after weight-loss drug snub – report
Original source: https://www.investing.com/news/stock-market-news/eli-lilly-drops-cvs-as-employee-drug-plan-after-weightloss-drug-snub–report-93CH-4349906
Read More »Novo Nordisk, Eli Lilly rise after Viking obesity trial data
Original source: https://www.investing.com/news/stock-market-news/novo-nordisk-eli-lilly-rise-after-viking-obesity-trial-data-4200015
Read More »Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports
Original source: https://www.investing.com/news/stock-market-news/eli-lilly-nears-13-billion-deal-for-geneediting-biotech-verve-therapeutics-ft-reports-4098210
Read More »Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy in weight loss trial
Original source: https://www.investing.com/news/stock-market-news/eli-lillys-zepbound-outperformsnovo-nordisks-wegovy-in-weight-loss-trial-4037781
Read More »Whistleblower sues Eli Lilly over drug manufacturing problems
Original source: https://www.investing.com/news/stock-market-news/whistleblower-sues-eli-lilly-over-drug-manufacturing-problems-2834131
Read More »US Equities – Open higher to start the week
USA500, Daily The key USA500 closed last week up 1.78 points on Friday at 3340, but down for the second consecutive week. The USA30 was also positive for Friday, closing…
Read More »